Leukemia Clinical Trials

Showing 861-880 of 5,235 trials

Immune Profile of Acute Myeloid Leukemia Patients Receiving Azacitidine Plus Venetoclax Induction Chemotherapy

NCT06279572

This study investigates the immune profile of patients receiving treatment with venetoclax plus azacitidine for acute myeloid leukemia (AML). Studying the information gathered from the immune profile from blood and bone marrow samples may help researchers understand the associated responses to the treatment of patients undergoing therapy of venetoclax plus azacitidine and create future immune based treatment approaches.

Acute Myeloid Leukemia

Mayo Clinic80 participantsStarted Apr 2021

Scottsdale, Arizona, United States • Jacksonville, Florida, United States • Rochester, Minnesota, United States

RECRUITINGNA

Fall Risk Assessment With an Innovative Device for Quantifying Gait and Static Balance in Geriatric Consultation

NCT06535477

The main objective of this monocentric, non-randomized, prospective study was to evaluate the predictive capacity of a balance score based on spatio-temporal parameters of postural balance.

Risk of Falling in the Elderly

Gérond'if169 participantsStarted Jul 2024

Ivry-sur-Seine, IIe-de-France, France

RECRUITINGPHASE3

A Study of SIM0270 Combined With Everolimus vs. Treatment of Physician's Choice in Patients With ER+/HER2- Advanced Breast Cancer (SIMRISE)

NCT06680921

This Phase III, randomized, open label, multicenter study will evaluate the efficacy and safety of SIM0270 combined with everolimus compared to physician's choice of treatment in subjects with ER+/HER2- locally advanced or metastatic breast cancer who have had previous treatment with CDK4/6 inhibitor.

Locally Advanced or Metastatic Breast Cancer

Jiangsu Simcere Pharmaceutical Co., Ltd.460 participantsStarted Nov 2024

Bengbu, Anhui, China • Hefei, Anhui, China • Hefei, Anhui, China +57 more locations

Immune Profile of Acute Myeloid Leukemia Patients Receiving Azacitidine Plus Venetoclax Induction Chemotherapy

Fall Risk Assessment With an Innovative Device for Quantifying Gait and Static Balance in Geriatric Consultation

A Study of SIM0270 Combined With Everolimus vs. Treatment of Physician's Choice in Patients With ER+/HER2- Advanced Breast Cancer (SIMRISE)

Related Searches

Turkish Version of the Hammersmith Neonatal Neurological Examination (HNNE)

Benefits Study of Respiratory-gated PET Acquisition in Lung Disease

Clinical Effectiveness Assessment of VeriStrat® Testing and Validation of Immunotherapy Tests in NSCLC Subjects

Childhood Cancer Survivors' Affective Response to Exercise

Feasibility of an Adapted Sports Program Based on Fencing to Reduce Physical Deconditioning in Adult Hematology Patients

Assessment of Marginal and Internal Fit of High Performance Polymer PEEK Endocrown Using Two Preparation Designs

SUNSET: SBRT for Ultra-central NSCLC- a Safety and Efficacy Trial

A Study of BL-M14D1 in Patients With Locally Advanced or Metastatic Small Cell Lung Cancer, Neuroendocrine Tumors and Other Solid Tumors

Serplulimab Combined With Induction Chemotherapy and Radiotherapy in Nasopharyngeal Carcinoma

Data and Sample Collection Study to Elucidate the Mechanisms of Eosinophilic Disorders

Clinical Benefit and Biomarker Analysis of Combination of PD-1/PD-L1 Immune Checkpoint Inhibitors and Radiotherapy

Nasal Allergen Challenge Test as a Method to Detect Clinical Reactivity Against Birch Pollen

Study of FIH of STX-241 in Locally Advanced or Metastatic NSCLC Resistant to EGFR TKIs

Study of JSKN016 Combination Therapy in Inoperable Locally Advanced or Metastatic HER2-Negative Breast Cancer

Primary Tumor Resection Plus Osimertinib in Advanced EGFR-mutant Non-small Cell Lung Cancer

HEM-iSMART E: Capivasertib + Venetoclax + Dexamethasone in Pediatric Patients With Relapsed or Refractory Hematological Malignancies

Genetically Modified T-cell Immunotherapy in Treating Patients With Relapsed/Refractory Acute Myeloid Leukemia and Persistent/Recurrent Blastic Plasmacytoid Dendritic Cell Neoplasm